Classification Nuance. The OpenFDA dataset, which draws from the Structured Product Labeling (SPL) files, often includes multiple classification fields, and the specific string "Phosphate Binder [EPC]" may only be assigned to a single product. The other drugs are likely classified using: More Specific Classes: Many of those drugs (like sevelamer, ferric citrate, etc.) may be classified by their specific mechanism or chemical group, which also acts as a phosphate binder. Example: A drug might be classified as "Iron-Containing Compound [EPC]" or "Aluminum-Containing Compound [EPC]" instead of the more general "Phosphate Binder [EPC]". Different Classification Fields: The NDC data contains several classification fields. You might be checking the Established Pharmacological Class (pharm_class_epc), but the other drugs might be listed under: Mechanism of Action (pharm_class_moa), Physiological Effect (pharm_class_pe)
  Home  

Enter a class name or drug name above to search the database.

Interleukin-23 Antagonist [EPC]

NDC Number Brand Name Generic Name Manufacturer Dosage Form DEA Sch. Marketing Start Date
0002-3116 Omvoh mirikizumab-mrkz Eli Lilly and Company INJECTION, SOLUTION 2025-04-03
0002-7575 Omvoh mirikizumab-mrkz Eli Lilly and Company INJECTION, SOLUTION 2023-10-26
0002-7717 Omvoh mirikizumab-mrkz Eli Lilly and Company KIT 2025-01-15
0002-7722 Omvoh mirikizumab-mrkz Eli Lilly and Company KIT 2025-01-15
0002-8011 Omvoh mirikizumab-mrkz Eli Lilly and Company INJECTION, SOLUTION 2023-10-26
0002-8870 Omvoh mirikizumab-mrkz Eli Lilly and Company INJECTION, SOLUTION 2024-04-29
0074-1050 Skyrizi risankizumab-rzaa AbbVie Inc. INJECTION 2021-04-26
0074-1065 Skyrizi Risankizumab-rzaa AbbVie Inc. KIT 2022-09-23
0074-1070 Skyrizi Risankizumab-rzaa AbbVie Inc. KIT 2022-06-16
0074-2100 Skyrizi risankizumab-rzaa AbbVie Inc. INJECTION 2021-04-26
0074-5015 Skyrizi risankizumab-rzaa AbbVie Inc. INJECTION 2022-06-16
0074-7040 Skyrizi Risankizumab-rzaa AbbVie Inc. KIT 2024-03-04
0074-7042 Skyrizi Risankizumab-rzaa AbbVie Inc. KIT 2024-03-04
0074-8300 Skyrizi risankizumab-rzaa AbbVie Inc. INJECTION 2025-09-03
0074-8350 Skyrizi risankizumab-rzaa AbbVie Inc. INJECTION 2025-09-03
47335-177 ILUMYA tildrakizumab-asmn Sun Pharmaceutical Industries, Inc. INJECTION, SOLUTION 2018-08-06
51407-929 IMULDOSA ustekinumab-srlf Golden State Medical Supply, Inc. INJECTION 2024-10-10
51407-930 IMULDOSA ustekinumab-srlf Golden State Medical Supply, Inc. INJECTION 2024-10-10
51407-931 IMULDOSA ustekinumab-srlf Golden State Medical Supply, Inc. INJECTION 2024-10-10
57894-054 Stelara ustekinumab Janssen Biotech, Inc. SOLUTION 2016-09-23
57894-060 STELARA ustekinumab Janssen Biotech, Inc. INJECTION, SOLUTION 2009-09-25
57894-061 STELARA ustekinumab Janssen Biotech, Inc. INJECTION, SOLUTION 2009-09-25
57894-440 ustekinumab ustekinumab Janssen Biotech, Inc. INJECTION, SOLUTION 2025-04-01
57894-441 ustekinumab ustekinumab Janssen Biotech, Inc. INJECTION, SOLUTION 2025-04-01
57894-444 ustekinumab ustekinumab Janssen Biotech, Inc. SOLUTION 2025-04-01
57894-640 TREMFYA Guselkumab Janssen Biotech, Inc. INJECTION 2017-07-13
57894-650 TREMFYA Guselkumab Janssen Biotech, Inc. INJECTION 2024-09-11
57894-651 TREMFYA guselkumab Janssen Biotech, Inc. INJECTION 2024-09-11
61314-651 PYZCHIVA ustekinumab-ttwe SANDOZ INC INJECTION, SOLUTION 2025-02-22
61314-652 PYZCHIVA ustekinumab-ttwe SANDOZ INC INJECTION, SOLUTION 2025-02-22
61314-654 PYZCHIVA ustekinumab-ttwe SANDOZ INC INJECTION, SOLUTION 2025-02-22
65219-822 Otulfi ustekinumab-aauz Fresenius Kabi USA, LLC INJECTION, SOLUTION 2025-09-29
65219-824 Otulfi ustekinumab-aauz Fresenius Kabi USA, LLC INJECTION, SOLUTION 2024-02-22
65219-826 Otulfi ustekinumab-aauz Fresenius Kabi USA, LLC INJECTION, SOLUTION 2024-02-22
65219-828 Otulfi ustekinumab-aauz Fresenius Kabi USA, LLC SOLUTION 2024-02-22
69448-017 IMULDOSA ustekinumab-srlf Accord BioPharma Inc. INJECTION 2024-10-14
69448-018 IMULDOSA ustekinumab-srlf Accord BioPharma Inc. INJECTION 2024-10-14
69448-019 IMULDOSA ustekinumab-srlf Accord BioPharma Inc. INJECTION 2024-10-18
82009-160 USTEKINUMAB-TTWE ustekinumab-ttwe Quallent Pharmaceuticals Health LLC INJECTION, SOLUTION 2025-04-15
82009-162 USTEKINUMAB-TTWE ustekinumab-ttwe Quallent Pharmaceuticals Health LLC INJECTION, SOLUTION 2025-04-15
82009-163 USTEKINUMAB-TTWE ustekinumab-ttwe Quallent Pharmaceuticals Health LLC INJECTION, SOLUTION 2025-04-15
83257-023 YESINTEK ustekinumab Biocon Biologics Inc. INJECTION, SOLUTION 2025-02-22
83257-024 YESINTEK ustekinumab Biocon Biologics Inc. INJECTION, SOLUTION 2025-02-22
83257-025 YESINTEK ustekinumab Biocon Biologics Inc. INJECTION, SOLUTION 2025-02-22
83257-026 YESINTEK ustekinumab Biocon Biologics Inc. SOLUTION 2025-02-22
83457-651 PYZCHIVA ustekinumab-ttwe Cordavis Limited INJECTION, SOLUTION 2025-05-01
83457-652 PYZCHIVA ustekinumab-ttwe Cordavis Limited INJECTION, SOLUTION 2025-05-01
83457-654 PYZCHIVA ustekinumab-ttwe Cordavis Limited INJECTION, SOLUTION 2025-05-01
84612-055 WEZLANA ustekinumab-auub Optum Health Solutions (Ireland) Limited INJECTION, SOLUTION 2025-01-01
84612-066 WEZLANA ustekinumab-auub Optum Health Solutions (Ireland) Limited INJECTION, SOLUTION 2025-01-01
84612-076 WEZLANA ustekinumab-auub Optum Health Solutions (Ireland) Limited INJECTION, SOLUTION 2025-01-01
84612-089 WEZLANA ustekinumab-auub Optum Health Solutions (Ireland) Limited INJECTION, SOLUTION 2025-01-01
84612-855 WEZLANA ustekinumab-auub Optum Health Solutions (Ireland) Limited INJECTION, SOLUTION 2025-01-01
84612-876 WEZLANA ustekinumab-auub Optum Health Solutions (Ireland) Limited INJECTION, SOLUTION 2025-01-01
84612-889 WEZLANA ustekinumab-auub Optum Health Solutions (Ireland) Limited INJECTION, SOLUTION 2025-01-01



 [EPC] Established Pharmacological Classification 

Loading full table content...